NextPlat (NXPL) Cash from Investing Activities Growth (1y) (2016 - 2025)
Powered by 
Analysis
NextPlat (NXPL) Cash from Investing Activities Growth (1y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -308.05% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.71% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 118.07% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -362.36% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 7.00% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 55.80% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 7,279.20% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -232.14% |
| Jun 30, 2025 | 113.07% |
| Mar 31, 2025 | 65.08% |
| Dec 31, 2024 | 114.81% |
| Jun 30, 2024 | 11.22% |
| Mar 31, 2024 | 8.70% |
| Dec 31, 2023 | 22.82% |
| Sep 30, 2023 | 191.73% |
| Jun 30, 2023 | -215.97% |
| Mar 31, 2023 | -1.48% |
| Dec 31, 2022 | -83.15% |
| Sep 30, 2022 | -10,252.41% |
| Jun 30, 2022 | -1,121.58% |
| Mar 31, 2022 | -14,714.16% |
| Dec 31, 2021 | -3,121.13% |
| Sep 30, 2021 | -1,388.13% |
| Jun 30, 2021 | -75.94% |
| Mar 31, 2021 | 95.80% |
| Dec 31, 2020 | 77.90% |
| Sep 30, 2020 | 84.83% |